Kent Holtorf, MD

Kent Holtorf, MD is the medical director of the Holtorf Medical Group (HoltorfMed.com) (had 22 centers and 9 franchises) and the founder and medical director of the non-profit National Academy of Hypothyroidism (NAHypothyroidism.org). He is also the founder of Integrative Peptides (Integrative Peptides.com), bringing doctors and patients the highest quality natural bioidentical peptides as supplements with unique delivery systems and dedicated to training physicians about ground-breaking peptide therapies. He has recently started a pharmaceutical company, KJ Biopharm, and proceeding with IND clinical trials on unique peptide and biologic therapies for complex immune-related conditions.

Dr. Holtorf is an internationally known lecturer, author, and innovator in cutting-edge research and treatments. He has lectured at almost 100 CME-approved medical society conferences and summits. He is on the Steering Committee and lecturer for the A4M/International Peptide Society and was the Endocrinology Expert for AOL Health; he has published multiple peer-reviewed endocrine review articles on complex, multisystem, poorly understood conditions, which demonstrates that much of the long-held dogma in endocrinology and infectious disease is inaccurate. He is also a guest editor and peer-reviewer for multiple medical journals, including the journal Endocrine.

He has been a featured guest on numerous major news outlets and print media, including CNBC, ABC News, CNN, Fox News, Good Morning America, The Today Show, Discovery Health, The Doctors, The Learning Channel, the Wall Street Journal, Los Angeles Times, US News and World Report, San Francisco Chronicle, WebMD, and Forbes, among many others.

An Updated Immune Modulatory Protocol for the Rapid Treatment of CIRS and Mold Illness